Figure 2.
Meta-analysis of the association between glypican-3(GPC3) overexpression and disease-free survival (DFS) of patients with HCC. Results are presented as individual and pooled hazard ratio (HR), and 95% confidence interval (CI).
Meta-analysis of the association between glypican-3(GPC3) overexpression and disease-free survival (DFS) of patients with HCC. Results are presented as individual and pooled hazard ratio (HR), and 95% confidence interval (CI).